title: Effect of the carboxylic ionophore monensin on histamine release from rat peritoneal mast cells.
abstract: The effect of the monovalent carboxylic ionophore monensin, which mediates a one-for-one exchange of intracellular H+ for extracellular Na+, was investigated in purified rat peritoneal mast cells. Monensin inhibited histamine secretion induced by compound 48/80, adriamycin and the calcium ionophore A23187; the inhibitory effect was maximal when the compound was added at least 10 min before the secretagogues. Washing of cells before addition of the secretagogues did not abolish the inhibitory effect of monensin. On the contrary the carboxylic ionophore was completely ineffective in preventing concanavalin A-induced histamine release. When rat peritoneal mast cells were incubated in the presence of monensin for longer period (up to 5 hours), the substance induced a slow, progressive and dose dependent histamine release, which, at least for lower doses was noncytotoxic. The secretory effect of monensin was still present if the ionophore was washed away after 10 min of incubation, and the incubation continued in drug-free medium. Monensin stimulated histamine secretion was strictly dependent on extracellular Na+ concentrations, and independent on extracellular Ca++.
authors.affiliation: Institute of Pharmacology, School of Medicine, University of Trieste, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Decorti
authors.forename: F
authors.initials: F
authors.lastname: Bartoli Klugmann
authors.forename: E
authors.initials: E
authors.lastname: Crivellato
authors.forename: F
authors.initials: F
authors.lastname: Mallardi
authors.forename: L
authors.initials: L
authors.lastname: Candussio
authors.forename: L
authors.initials: L
authors.lastname: Baldini
mesh_terms: D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects*; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D008985:Monensin / Q000008:administration & dosage / Q000494:pharmacology*; D010529:Peritoneal Cavity / Q000166:cytology*; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000494:pharmacology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
chemical_list: D003208:Concanavalin A; D000001:Calcimycin; D003189:p-Methoxy-N-methylphenethylamine; D004317:Doxorubicin; D008985:Monensin; D012964:Sodium; D002118:Calcium